TRAMETINIB EXPERIENCE IN A BRAF P.N 486 _P490DEL MUTATION POSITIVE LANGERHANS CELL HISTIOCYTOSISSevim Gencel Karaaslan, Emel Ünal, Işınsu Kuzu et al.|Hematology Transfusion and Cell Therapy|2022Cited by 0
Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-Year Follow-up with Successful Sorafenib TreatmentSirmen Kızılcan Çetin, Merih Berberoğlu, Zeynep Şıklar et al.|Journal of Clinical Research in Pediatric Endocrinology|2023Cited by 0
Keratin-Positive Giant Cell-Rich Tumor in Early Infancy: Metastatic Presentation and Imatinib ResponseCEM Canakci, Nurdan Taçyildiz, Nubar Mustafayeva et al.|Journal of Pediatric Hematology/Oncology|2026Cited by 0